BioVie Inc. Stock-Based Compensation
BioVie Inc. (BIVI) reported Stock-Based Compensation of $2.28 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-13
- BioVie Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $256.72K, a 27.24% decline year-over-year.
- BioVie Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $1.56M, a 361.38% increase year-over-year.
- BioVie Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $197.34K, a 48.79% decline year-over-year.
- BioVie Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $268.39K, a 125.73% increase year-over-year.
- BioVie Inc. share-based payment arrangement, noncash expense for fiscal 2026 was $2.28M, a 91.04% increase from fiscal 2025.
- BioVie Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $1.20M.
- BioVie Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $4.22M, a 27.29% decline from fiscal 2022.
- BioVie Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $5.81M, a 92.33% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 4 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $256.72K derived: 10-K 12 month − S-1/A 9 month · filed 2026-08-13 | $1.82M derived: sum of 2 quarters · filed 2026-08-13 | $2.02M derived: sum of 3 quarters · filed 2026-08-13 | $2.28M 10-K · filed 2026-08-13 | |
| 2026-03-31 | $1.56M derived: S-1/A 9 month − 10-Q 6 month · filed 2026-08-06 | $1.76M derived: sum of 2 quarters · filed 2026-08-06 | $2.03M S-1/A · filed 2026-08-06 | $2.38M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-12-31 | $197.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-06 | $465.72K 10-Q · filed 2026-02-06 | $818.53K derived: sum of 3 quarters · filed 2026-08-13 | $1.16M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-09-30 | $268.39K 10-Q · filed 2025-11-10 | $621.20K derived: sum of 2 quarters · filed 2026-08-13 | $959.61K derived: sum of 3 quarters · filed 2026-08-13 | $1.34M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-06-30 | $352.81K derived: 10-K 12 month − S-1/A 9 month · filed 2026-08-13 | $691.22K derived: sum of 2 quarters · filed 2026-08-13 | $1.08M derived: sum of 3 quarters · filed 2026-08-13 | $1.20M 10-K · filed 2026-08-13 | |
| 2025-03-31 | $338.41K derived: S-1/A 9 month − 10-Q 6 month · filed 2026-08-06 | $723.74K derived: sum of 2 quarters · filed 2026-08-06 | $842.64K S-1/A · filed 2026-08-06 | $1.55M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2024-12-31 | $385.33K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-06 | $504.23K 10-Q · filed 2026-02-06 | $1.21M derived: sum of 3 quarters · filed 2026-08-06 | $1.90M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2024-09-30 | $118.90K 10-Q · filed 2025-11-10 | $824.01K derived: sum of 2 quarters · filed 2026-08-06 | $1.51M derived: sum of 3 quarters · filed 2026-08-06 | $2.13M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2024-06-30 | $705.12K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-08-06 | $1.40M derived: sum of 2 quarters · filed 2026-08-06 | $2.02M derived: sum of 3 quarters · filed 2026-08-06 | $2.82M S-1/A · filed 2026-08-06 | |
| 2024-03-31 | $690.92K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-12 | $1.31M derived: sum of 2 quarters · filed 2025-05-12 | $2.12M 10-Q · filed 2025-05-12 | $2.86M derived: sum of 4 quarters · filed 2025-05-12 | |
| 2023-12-31 | $619.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-11 | $1.43M 10-Q · filed 2025-02-11 | $2.17M derived: sum of 3 quarters · filed 2025-02-11 | $3.06M derived: sum of 4 quarters · filed 2025-02-11 | |
| 2023-09-30 | $808.03K 10-Q · filed 2024-11-13 | $1.55M derived: sum of 2 quarters · filed 2024-11-13 | $2.44M derived: sum of 3 quarters · filed 2024-11-13 | $4.15M derived: sum of 4 quarters · filed 2024-11-13 | |
| 2023-06-30 | $742.42K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | $1.63M derived: sum of 2 quarters · filed 2024-09-30 | $3.34M derived: sum of 3 quarters · filed 2024-09-30 | $4.22M 10-K · filed 2024-09-30 | |
| 2023-03-31 | $889.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-14 | $2.60M derived: sum of 2 quarters · filed 2024-05-14 | $3.48M 10-Q · filed 2024-05-14 | $5.28M derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | $1.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-13 | $2.59M 10-Q · filed 2024-02-13 | $4.39M derived: sum of 3 quarters · filed 2024-02-13 | $5.32M derived: sum of 4 quarters · filed 2024-02-13 | |
| 2022-09-30 | $878.64K 10-Q · filed 2023-11-08 | $2.68M derived: sum of 2 quarters · filed 2023-11-08 | $4.00M 10-Q · filed 2022-05-11 | $4.76M derived: sum of 4 quarters · filed 2023-11-08 | |
| 2022-06-30 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-16 | $2.73M derived: sum of 2 quarters · filed 2023-08-16 | $3.88M derived: sum of 3 quarters · filed 2023-08-16 | $5.81M 10-K · filed 2023-08-16 | |
| 2022-03-31 | $930.33K 10-Q · filed 2022-05-11 | $2.08M derived: sum of 2 quarters · filed 2022-05-11 | $4.00M 10-Q · filed 2023-05-12 | $4.68M derived: sum of 4 quarters · filed 2022-11-04 | |
| 2021-12-31 | $1.15M 10-Q · filed 2022-05-11 | $3.07M 10-Q · filed 2023-02-10 | $3.75M derived: sum of 3 quarters · filed 2022-11-04 | $4.56M derived: sum of 4 quarters · filed 2022-11-04 | |
| 2021-09-30 | $1.93M 10-Q · filed 2022-11-04 | $2.61M derived: sum of 2 quarters · filed 2022-11-04 | $2.34M 10-Q · filed 2022-05-11 | $4.95M derived: sum of 4 quarters · filed 2022-11-04 | |
| 2021-06-30 | $679.28K derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-27 | $1.48M derived: sum of 2 quarters · filed 2022-09-27 | $3.02M derived: sum of 3 quarters · filed 2022-09-27 | $3.02M 10-K · filed 2022-09-27 | |
| 2021-03-31 | $803.60K 10-Q · filed 2022-05-11 | $2.34M derived: sum of 2 quarters · filed 2022-05-11 | $2.34M 10-Q · filed 2021-05-10 | ||
| 2020-12-31 | $1.54M 10-Q · filed 2022-05-11 | $1.54M 10-Q · filed 2021-05-10 | $1.54M 10-Q · filed 2022-02-08 | ||
| 2020-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-30 | $13.68K derived: sum of 2 quarters · filed 2021-08-30 | $24.85K derived: sum of 3 quarters · filed 2021-08-30 | $24.85K 10-K · filed 2021-08-30 | |
| 2020-03-31 | $13.68K 10-Q · filed 2021-05-10 | $24.85K derived: sum of 2 quarters · filed 2021-05-10 | $24.85K 10-Q · filed 2021-05-10 | ||
| 2019-12-31 | $11.16K 10-Q · filed 2021-05-10 | $11.16K 10-Q · filed 2021-01-29 | |||
| 2019-06-30 | $1.55K derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-08-07 | $45.16K derived: sum of 2 quarters · filed 2020-08-07 | $61.45K derived: sum of 3 quarters · filed 2020-08-07 | $64.86K 10-K/A · filed 2020-08-07 | |
| 2019-03-31 | $43.61K 10-Q · filed 2020-05-13 | $59.89K derived: sum of 2 quarters · filed 2020-05-13 | $63.31K 10-Q · filed 2020-05-13 | -$509.73K derived: sum of 4 quarters · filed 2020-05-13 | |
| 2018-12-31 | $16.29K 10-Q · filed 2020-05-13 | $19.70K 10-Q · filed 2020-02-13 | -$553.34K derived: sum of 3 quarters · filed 2020-05-13 | -$401.28K derived: sum of 4 quarters · filed 2020-05-13 | |
| 2018-09-30 | $3.41K 10-Q · filed 2020-05-13 | -$569.63K derived: sum of 2 quarters · filed 2020-05-13 | -$417.56K derived: sum of 3 quarters · filed 2020-05-13 | -$390.54K derived: sum of 4 quarters · filed 2020-05-13 | |
| 2018-06-30 | -$573.04K derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-27 | -$420.98K derived: sum of 2 quarters · filed 2019-09-27 | -$393.95K derived: sum of 3 quarters · filed 2019-09-27 | $238.16K 10-K · filed 2019-09-27 | |
| 2018-03-31 | $152.06K 10-Q · filed 2019-05-10 | $179.08K derived: sum of 2 quarters · filed 2019-05-10 | $811.20K 10-Q · filed 2019-05-10 | ||
| 2017-12-31 | $27.02K 10-Q · filed 2019-05-10 | $39.77K 10-Q · filed 2019-02-12 | |||
| 2017-09-30 | $12.75K 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |